[Antifibrous action of polyvinyl-pyridine-N-oxides in experimental silicosis].
D000284:Administration, Oral; D000818:Animals; D003497:Cyclic N-Oxides / Q000627:therapeutic use; D007279:Injections, Subcutaneous; D008297:Male; D008970:Molecular Weight; D011145:Polyvinyls / Q000627:therapeutic use*; D011725:Pyridines / Q000627:therapeutic use*; D051381:Rats; D012829:Silicosis / Q000188:drug therapy* / Q000473:pathology; D013997:Time Factors
D003497:Cyclic N-Oxides; D011145:Polyvinyls; D011725:Pyridines
Protivofibroznoe deĭstvie polivinil-piridin-N-oksidov pri éksperimental'nom silikoze.